ONCOLOGY RES INTERNATIONAL LIMITED has a total of 16 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Australia, Brazil and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SUZHOU NEUPHARMA CO LTD, DAVIDSON LOPEZ LLC and HARBOR BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Brazil | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Taiwan | 2 | |
#5 | Canada | 1 | |
#6 | Mexico | 1 | |
#7 | United States | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Steroids | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars | |
#5 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Marshall Philip Andrew | 9 |
#2 | Kelly Peter | 6 |
#3 | Walker David Millar | 4 |
#4 | Mason Jennifer Mary | 3 |
#5 | David Millar Walker | 3 |
#6 | Philip Andrew Marshall | 3 |
#7 | Andrew Clive Muscroft-Taylor | 2 |
#8 | Wayte Kenneth Michael | 2 |
#9 | Muscroft-Taylor Andrew Clive | 2 |
#10 | Story Michael John | 2 |
Publication | Filing date | Title |
---|---|---|
AU2018217439A1 | Steroid saponins with anti-cancer activity | |
AU2013203998A1 | Polymorph | |
AU2013204005A1 | Improved synthesis |